BioImagine EMBLEM Seminars
DAY 1 – 31.05.2011 (Tuesday) – Nencki Institute of Experimental Biology PAS
10.00 – 11.30 – Workshop part 1
11.30 – 12.00 – Coffee Break
12.00 – 13.30 – Workshop part 2
13.30 – 14.30 – Lunch
Dr. Martin Raditch
“Add value to knowledge” (duration 3 h)
This workshop will show examples how to add value to existing research programs and inventions of your institutions using the technology transfer toolbox. Further more you will get ideas, how to set-up the contractual and financial frame-work and last but not least you will have the chance to learn from success stories as well as failures in form of case studies.
DAY 2 – 02.06.2011 (Thursday) – Nencki Institute of Experimental Biology PAS
10.30 – 12.00 – ““Introduction to Intellectual Property Rights and Technology Transfer”
Dr. Gábor Lamm
Dr. Birgit Kerber
(duration 60 minutes)
This general seminar describes the technology transfer process in an academic basic research setting; gives an overview (with examples) about the different types of Intellectual Property Rights (IPR); the criteria required for filing patent application(s); and what Material Transfer Agreements (MTAs) and Confidentiality [Non-Disclosure] Agreements (CDAs/NDAs) are good for. The seminar also covers the “does” and “don’ts” for innovators working in an academic setting and what to watch out for when dealing with commercial partners.
12.00 – 12.30 – Coffe Break
12.30 – 14.30 - “Function defines Structure: how to set-up a successful Technology Transfer Office”
Dr. Gabor Lamm
(duration 90 minutes)
Is Technology Transfer (TT) best managed as an internal activity of the University/Research Institute or as an external entity? How should the TT activities be structured and managed? How do you find that rare specimen, the TT-officers, with one leg in industry and the other in academia? And once you recruit them, how do you manage to motivate and retain them? This specialised seminar aims to provide answers to all of these questions and is aimed at high-level decision makers at Universities and Research Institutes, Politicians and Technology Transfer Professionals.
14.30 – 15.30 Lunch
EMBLEM Technology Transfer GmbH
Martin Raditsch, PhD
Deputy Managing Director
Martin Raditsch is a graduate of Heidelberg University and holds a Ph.D. in Molecular Biology.
Following his Ph.D., Martin was Laboratory Leader in the pharmaceutical R&D division of BASF AG. After positions in international product marketing in the agrochemical sector of the corporation and plant biotech project management, he became Head of Technology Management and was responsible for the applied technology portfolio of the plant biotech entity with activities based in the US, Canada, Sweden and Germany.
In July 2001 Martin joined EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) (www.embl-em.de), a fully owned subsidiary of the European Molecular Biology Laboratory (EMBL) (www.embl.de) as Head of Business Development responsible for the commercialisation of intellectual property developed in the EMBL-world. As of January 2004 he is Deputy Managing Director of EMBLEM.
Martin is an alumnus of the Max-Planck-Society, the St. Gallen Business School and a member of several professional societies such as LES, ASTP.
Gábor M. Lamm, Ph.D
Dr. Lamm (born 1967 in Budapest) is a graduate of Edinburgh University (Biochemistry) and holds a Ph.D. in Molecular Biology.
After spending three years as a research scientist at the Boehringer Ingelheim Institute of Molecular Pathology (IMP) in Vienna, Dr. Lamm joined Wacker Chemie, a major global supplier of silicone and polymer raw materials and semi-conductors. At Wacker Chemie, Dr. Lamm was Business-Team Leader in the division specialising in advanced ceramic components for high-tech applications. As of October 2000 he is Managing Director of EMBL Enterprise Management Technology Transfer GmbH (EMBLEM; http://www.embl-em.de), the wholly owned subsidiary of the European Molecular Biology Laboratory (EMBL; www.embl.org).
Dr. Lamm is an alumnus of the European Molecular Biology Laboratory Ph.D. program and of the Boehringer Ingelheim Fonds and is co-founder of the EMBL Technology Fund (ETF) [www.embl-ventures.com]. He is on the board of directors of the BioRegio RND e. V. (Heidelberg) and former vice-president (2002-2006) of the Association of European Science and Technology Transfer Professionals (ASTP).
Birget Kerber, Ph.D
EMBLEM Business Development Manager
Dr. Kerber is a graduate of Marburg University (Molecular Genetics). She did her Ph.D. thesis at the Max-Planck-Institute for biophysical chemistry in Göttingen and was awarded a Ph.D. in Biology in 1998.
After spending three years as a postdoctoral scientist at the European Molecular Biology Laboratory in Heidelberg (EMBL), Dr. Kerber joined EMBL Enterprise Management Technology Transfer GmbH in 2001, where she currently is Business Development Manager.
For her Ph.D. and postdoctoral work, Dr. Kerber held fellowships of the Boehringer Ingelheim Fonds, the Deutsche Forschungsgemeinschaft (DFG) and the European Molecular Biology Organisation (EMBO). Dr. Kerber is a member of the Association of European Science and Technology Transfer Professionals (ASTP) and of the Licensing Executives Society (LES).
About EMBLEM (http://www.embl-em.de/)
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). EMBL established in 1974 is a basic research institute funded by public research funds from 20 member states, including most of the EU, Switzerland and Israel. EMBLEM identifies, protects and commercialises the intellectual property developed in the EMBL-world, from EMBL-alumni and from non-EMBL third parties. EMBLEM facilitates and accelerates the transfer of innovative technology from basic research to industry by working closely with industrial partners spanning the biotech, pharmaceutical, IT and mechanical/electrical engineering markets.
The European Molecular Biology Laboratory (EMBL) is a basic research institute funded by public research funds from 20 member states, including most of the EU, Switzerland and Israel. Research at EMBL is conducted by approximately 80 independent groups, covering the spectrum of molecular biology. The Laboratory has five units: the main Laboratory in Heidelberg, Outstations in Hinxton (the European Bioinformatics Institute), Grenoble (on the campus of the ILL and ESRF), Hamburg (on the DESY site), and an external research programme in Monterotondo, Italy (sharing a campus with EMMA and the CNR). The cornerstones of EMBL's mission are: to perform basic research in molecular biology, to train scientists, students and visitors at all levels, to offer vital services to scientists in the member states, and to develop new instruments, technologies and methods in the life sciences. The Laboratory also sponsors an active Science and Society programme.
For registration please contact Mr. Paweł Nowicki
Office of International Cooperation
and Project Management
Nencki Institute of Experimental Biology
Polish Academy of Sciences
02-093 Warsaw Poland
phone (+48 22) 589 2149 begin_of_the_skype_highlighting (+48 22) 589 2149 end_of_the_skype_highlighting
fax (+48 22) 589 2489
mobile (+48) 603 741 752 begin_of_the_skype_highlighting (+48) 603 741 752 end_of_the_skype_highlighting